Living Well With Multiple Myeloma: Understanding Genetics and Developing Research

September 09, 2017

An audience of myeloma patients and their caregivers joined us at a recent town meeting along with the UAMS Myeloma Institute to hear the latest treatment and research news, inspiring stories of people living well with myeloma, tips for effective communication with a healthcare team and more.

We are also planning events in other cities. If you haven’t already, please sign up for email updates so we can alert you when important and inspiring videos become available and when upcoming town meetings are scheduled.


Patient Folder


Can Genetic Profiles Change During Cancer Treatment?

Dr. Brian Walker and Dr. Frits van Rhee discuss the possibility of genetic mutations occurring and how it can affect treatment. Watch now to find out more.


Can Genetic Profiling in Myeloma Determine Treatment Strategies?

Dr. Faith Davies and Dr. Brian Walker share how tests revealing gene expression profile can improve care for myeloma patients.


Can Genetic Profiling Identify Higher Risk Myeloma?

What can a genetic profile reveal about your myeloma condition? Join us to hear from our expert panel how the information from this diagnostic test can lead to better treatment.


Understanding “Different Kinds of Clinical Trials” in Myeloma

A clinical trial may provide a beneficial alternative for myeloma patients, but at what point in the course of treatment is it appropriate to do one? Tune in to find out.


How Are Myeloma Experts Harnessing the Power of CAR T-Cell Therapy?

Dr. Frits van Rhee dives into CAR-T cell therapy, an emerging treatment that modifies a patient’s own immune system to fight their myeloma.


Biopsy and Imaging: How Do Experts Pinpoint Myeloma in the Body?

Dr. Faith Davies discusses technology and techniques experts today use to detect and diagnose myeloma.


Will Circulating Tumor DNA Test Replace Bone Biopsy Test in Myeloma?

Dr. Gareth Morgan and Dr. Brian Walker discuss new technology and research surfacing that may offer an alternative to bone marrow biopsy testing.


Host & Guests

Patient Advocate and Host


Professor of Medicine and Director of the UAMS Myeloma Institute

Professor of Medicine and Director of Phase I Clinical Trials Program

Professor of Medicine and Director of Developmental and Translational Medicine

Emeritus Professor of Medicine

University of Iowa Health Care

Professor and Director of Research, The Myeloma Institute

University of Arkansas for Medical Sciences

Myeloma Patient and Advocate

This town meeting was sponsored by Amgen, Janssen Pharmaceuticals and Takeda Oncology. It is produced by Patient Power in partnership with the UAMS Myeloma Institute.

Page last updated on November 17, 2017